Search

Author/Creator Carlino, Matteo S

1. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Eggermont, Alexander M M; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A; Rutkowski, Piotr; Schadendorf, Dirk;...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
643
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Bottomley, Andrew; Coens, Corneel; Mierzynska, Justyna; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Puig, Susana; Ascierto, Paolo A; Larkin, James; Loriga...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
655
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Issue 3 (March 2018)

Authors:
McQuade, Jennifer L; Daniel, Carrie R; Hess, Kenneth R; Mak, Carmen; Wang, Daniel Y; Rai, Rajat R; Park, John J; Haydu, Lauren E; Spencer, Christine; Wongchenko, Matthew; Lane, Stephen; Lee, Dung-Yang; Kaper, Mathilde; McKean, Meredith; Beckermann, Kathryn E; Rubinstein, Samuel M; Rooney, Isabell...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 3(2018)
Page Start:
310
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Circulating tumour DNA and melanoma survival: A systematic literature review and meta-analysis. (January 2021)

Authors:
Gandini, Sara; Zanna, Ines; De Angelis, Simone Pietro; Cocorocchio, Emilia; Queirolo, Paola; Lee, Jenny H; Carlino, Matteo S; Mazzarella, Luca; Achutti Duso, Bruno; Palli, Domenico; Raimondi, Sara; Caini, Saverio
Journal:
Critical reviews in oncology/hematology
Issue:
Volume 157(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. Issue 1 (19th January 2021)

Authors:
Rogiers, Aljosja; Pires da Silva, Ines; Tentori, Chiara; Tondini, Carlo Alberto; Grimes, Joseph M; Trager, Megan H; Nahm, Sharon; Zubiri, Leyre; Manos, Michael; Bowling, Peter; Elkrief, Arielle; Papneja, Neha; Vitale, Maria Grazia; Rose, April A N; Borgers, Jessica S W; Roy, Severine; Mangana, Jo...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. Issue 1 (19th January 2021)

Authors:
Rogiers, Aljosja; Pires da Silva, Ines; Tentori, Chiara; Tondini, Carlo Alberto; Grimes, Joseph M; Trager, Megan H; Nahm, Sharon; Zubiri, Leyre; Manos, Michael; Bowling, Peter; Elkrief, Arielle; Papneja, Neha; Vitale, Maria Grazia; Rose, April A N; Borgers, Jessica S W; Roy, Severine; Mangana, Jo...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. Issue 1 (19th January 2021)

Authors:
Rogiers, Aljosja; Pires da Silva, Ines; Tentori, Chiara; Tondini, Carlo Alberto; Grimes, Joseph M; Trager, Megan H; Nahm, Sharon; Zubiri, Leyre; Manos, Michael; Bowling, Peter; Elkrief, Arielle; Papneja, Neha; Vitale, Maria Grazia; Rose, April A N; Borgers, Jessica S W; Roy, Severine; Mangana, Jo...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma. (21st February 2022)

Authors:
Pennington, Thomas E; Zhao, Cathy Yunjia; Colebatch, Andrew J; Fernandez‐Peñas, Pablo; Guitera, Pascale; Burke, Hazel; Scolyer, Richard A; Menzies, Alexander M; Carlino, Matteo S; Lo, Serigne; Long, Georgina V; Saw, Robyn PM
Journal:
Australasian journal of dermatology
Issue:
Volume 63:Number 2(2022)
Page Start:
e133
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders. Issue 5 (7th May 2021)

Authors:
Brown, Lauren J; Weppler, Alison; Bhave, Prachi; Allayous, Clara; Patrinely Jr, J. Randall; Ott, Patrick; Sandhu, Shahneen; Haydon, Andrew; Lebbe, Celeste; Johnson, Douglas B; Long, Georgina V; Menzies, Alexander A; Carlino, Matteo S
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗